Introduction
Molecular biology works one level below genetics. Genetics can tell you a trait is inherited without knowing what carries it. Molecular biology asks which molecule, in what shape, doing what, and the answers turn out to be mechanical: strands separating, enzymes walking along them, chains folding into a working part.
Four processes cover most of it. Replication copies the genome. Transcription reads a gene into RNA. Translation builds a protein from that RNA. Regulation decides which of those happen, when, and how much, and regulation is where most of the interesting biology lives, because a cell with the wrong genes switched on is a cell in trouble regardless of how good its genome is.
History and Development
The answer arrived in two stages, and the first one puzzled everybody. In 1928 Frederick Griffith found that heat-killed virulent pneumococcus could turn a harmless strain virulent. Something had moved between dead cells and live ones. He called it the transforming principle and did not know what it was. Sixteen years later, in 1944, Oswald Avery, Colin MacLeod and Maclyn McCarty worked out which component carried the effect by destroying each candidate in turn. Remove the protein, transformation continued. Remove the DNA, it stopped.
Even then most biologists doubted it, since DNA looked too monotonous to encode anything. 1953 settled the argument by showing the structure. Then PCR made DNA something you could amplify from a vanishing sample, which is why forensics and diagnostics look the way they do, and the Human Genome Project finished in 2003 with a reference sequence everyone could work against.
Core Concepts
The central dogma names the direction information travels: DNA to RNA to protein. DNA replication copies the archive, transcription issues a working copy of one gene, and translation turns that copy into a protein. Calling it a dogma was Crick's word choice and he later admitted he had misused the term; the arrows also run backwards in places, which retroviruses demonstrate every time one copies RNA into DNA.
Regulation is the part that makes a body possible. Every cell carries the same genome, so a liver cell and a neuron differ by which genes they read. Transcription factors do the switching, binding DNA to recruit or block the transcription machinery. Epigenetics covers the marks layered on top, chemical tags on DNA and on the proteins it wraps around, which survive cell division and let a cell remember what kind of cell it was.
Cell Structure
Organelles are the cell's answer to a problem of concentration: reactions that would interfere with each other get put in separate rooms. The nucleus keeps the genome apart from the cytoplasm, which is why transcription and translation happen in different places and can be regulated separately. Mitochondria carry their own small genome, a leftover from the bacterium they descend from. Ribosomes are not membrane-bound at all, just a machine made of RNA and protein.
The cell membrane is a barrier that mostly says no. Two layers of lipid, oily in the middle, so water-soluble molecules cannot cross unaided and everything useful needs a dedicated channel or pump. That selectivity is what allows a cell to hold an internal chemistry different from its surroundings, which is a precondition for metabolism working at all. Apoptosis is the opposite case: a controlled self-destruction a cell runs on purpose, and cancer is partly the story of cells that stopped obeying it.
DNA and RNA
One letter of chemistry separates the two molecules, and it decides their jobs. DNA has a deoxyribose sugar, missing one oxygen, which makes it chemically dull and therefore durable: good for an archive you need to keep for a lifetime. RNA keeps that oxygen, which makes it reactive and short-lived: good for a disposable working copy. DNA structure and RNA processing both follow from that difference.
Processing is not a detail. A human gene is interrupted by stretches that never reach the protein, and splicing cuts them out. Splice the same gene differently and you get a different protein, which is one reason roughly 20,000 human genes can produce a far larger set of proteins. And not every RNA becomes one: many RNA types are the end product themselves, doing structural or regulatory work with no protein involved.
Gene Expression
Histones coil the DNA. A tight coil silences the gene inside it. Regulation starts as a physical job.
Promoters mark a gene's start. Enhancers sit anywhere: fifty thousand bases upstream, or inside the next gene along. The DNA loops and they reach their target anyway.
Diagrams fail at that point. Transcription factors work in committees. One factor activates here, represses there, and the neighbours cast the deciding vote. Break the switch and you get disease with the gene intact.
Molecular Techniques
Every technique here exists because of a specific obstacle.
Too little DNA to work with: PCR. Heat separates the strands, a primer marks where to start, an enzyme copies the span between. Thirty rounds of that converts a trace into a usable quantity.
A tube of mixed fragments and no way to tell them apart: gel electrophoresis. Charge drags the DNA through a mesh and small pieces move faster, so length shows up as distance.
An unknown protein in a sample: mass spectrometry, which weighs the fragments precisely enough to name them.
A protein whose shape you need: crystallography. Persuade it to crystallise, fire X-rays, read the diffraction. The persuading is the hard part and some proteins never comply.
Applications in Biotechnology
Diagnostics is where this field touches the most people, and almost nobody notices. A PCR test for an infection is molecular biology performed at industrial scale, and the pandemic made the whole population briefly fluent in its vocabulary. Gene therapy is the showpiece, correcting a faulty gene outright, though it works on a short list of conditions and costs accordingly.
Biopharmaceuticals are the quiet commercial centre of it. Insulin used to be extracted from pig and cattle pancreases; now a modified cell line produces human insulin in a tank, which is both a better drug and a supply that does not depend on slaughterhouse volumes. Genetically modified crops run the same logic in agriculture, and vaccine design increasingly starts from a sequence rather than a cultured pathogen.
Further Reading
For deeper study, explore these resources: